Molecular Psychiatry is a scientific journal published by Nature Publishing Group. It publishes papers in biological psychiatry and, e.g., about psychiatric genetics. With an impact factor of 15.407 the 2010 Journal Citation Reports ranked it 1 among 119 psychiatry journals and 5th among 237 neuroscience journals. Elsevier publishes a competing journal called Biological Psychiatry which broadly has similar scope. It is abstracted in:
Depression is one of the most common mental illnesses in the world, but current anti-depressants have yet to meet the needs of many patients. Neuroscientists from City University of Hong Kong (CityU) recently discovered a ...
Nov 16, 2023
0
53
A first-of-its-kind study has identified overactive inflammation and loss of critical protection mechanisms in the brain as potential contributors to suicide risk.
Nov 14, 2023
0
14
Mount Sinai researchers have shed valuable light on the mechanism of a key protein that regulates the plasticity and function of the hippocampus, a key brain region involved in memory and learning, and that decreases with ...
Nov 2, 2023
0
0
An early phase in the process of developing Alzheimer's disease is a metabolic increase in a part of the brain called the hippocampus, report researchers from Karolinska Institutet in a study published in Molecular Psychiatry. ...
Oct 31, 2023
0
177
The discovery of a physical interaction between two proteins in brain cells that can be traced in mice to control of movement, anxiety and memory could one day open the door to development of new schizophrenia treatment strategies, ...
Oct 26, 2023
0
15
The first-line pharmacological treatment for major depressive disorder (MDD) are antidepressant drugs known as selective serotonin re-uptake inhibitors (SSRIs). But a significant proportion of people don't respond to these ...
Oct 24, 2023
0
3
A new study led by researchers from the Barcelona Institute for Global Health (ISGlobal) has shed light on the influence that Endocrine-Disrupting Chemicals (EDCs) can have on children's growth during their early years. The ...
Oct 18, 2023
0
0
Most folks know that certain antidepressants have to be taken for a few weeks before people start seeing improvement, and now a new study sheds light on that delay.
Oct 17, 2023
0
40
A new research result from the University of Southern Denmark opens the door to the possibility of using psilocybin, the active compound in mushrooms with psychedelic properties, as a therapeutic tool through microdosing.
Oct 3, 2023
0
238
Until recently, our understanding of Parkinson's disease has been quite limited, which has been apparent in the limited treatment options for management of this debilitating condition.
Oct 2, 2023
0
41
